Researchers are reporting two promising approaches to counteract malaria's growing drug resistance. Switzerland-based ...

Promising results from a new malaria drug offer hope against emerging drug resistance in Africa. In a clinical trial, ...

Hundreds of malaria patients enrolled in a phase 3 clinical trial in Gabon, West Africa, were successfully treated with a one ...

Hundreds of malaria patients participating in a Phase 3 clinical trial in Gabon in West Africa were cured via a single dose ...

The drug, known as GanLum, is made by Swiss pharmaceutical giant Novartis. In a late-stage trial, it worked about as well as ...

The best drug to fight malaria is facing increased resistance from the parasites it fights. Now there's an alternative in the ...

The treatment — which could be the first novel antimalarial in decades — showed the ability in testing to combat drug ...

Novartis plans to seek quick regulatory approvals from health authorities for the drug, known as GanLum, which would be the ...

A new malaria drug, Ganaplacide/Lumefantrine, shows over 97% cure rates in trials. This treatment is effective even where ...

Switzerland-based Novartis has developed a new anti-malaria drug, GanLum, that showed 97% effectiveness in late-stage trials.

Scientists have created the first new anti- malaria drug in a quarter of a century to combat resistance to existing ...